[1] | Petrov M.S., Yadav D. Global epidemiology and comprehensive prevention of pancreatitis. \\ In Russian.\\ NatRevGastroenterolGepatol. 2019; 16 (3): 175–184. |
[2] | Gallyamov E.A., Agapov M.A., Lutsevich O.E., Kakotkin V.V. Modern technologies of treatment of infected pancreatic necrosis: a differentiated approach. \\ In Russian. \\ Annals of Surgical Hepatology. 2020; 25(1): 69-78. https://doi.org/10.16931/1995-5464.2020169-78. |
[3] | The use of umbilical cord blood and cord cord in the complex treatment of patients with necrotic pancreatitis / A. B. Kebkalo, G. S. Lobyntsev, V. I. Seminog, V. A. Shabli // In Russian. \\ Ukrainian Journal of Extreme Medicine named after G.A. Mozhaev. – 2012. – V. 13. – № 1. – P. 77-85. |
[4] | Brunschot SV, Bakker OJ, Besselink MG, et al. Treatment of necrotizing pancreatitis. Clinical Gastroenterology and Hepatology. 2012; 10(11): 1190–1201. |
[5] | Eric HJ, Daniel BC, Waddah BA, et al. Exocrine Pancreas. In: Townsend CM, et al. editors. Philadelphia; 2012. p. 1515–1531. |
[6] | Habtezion A., Gukovskaya A. S., Pandol S. J. (2019). Acute pancreatitis: a multifaceted set of organelles and cellular interactions. Gastroenterology, 156 (7), 1941-1950. https://doi.org/10.1053/j.gastro.2018.11.082. |
[7] | Forsmark CE, Vege SS, Wilcox CM. Acute pancreatitis. N Engl J Med 2016; 375: 1972–1981. |
[8] | Shah AP, Mourad MM, Bramhall SR. Acute pancreatitis: current perspectives on diagnosis and management. J Inflamm Res 2018; 11: 77-85. 10.2147/JIR.S135751. |
[9] | Machicado JD, Gougol A, Stello K, et al. Acute pancreatitis has a long-term deleterious effect on physical health related quality of life. ClinGastroenterolHepatol 2017; 15: 1435-43. e2. 10.1016/j.cgh.2017.05.037. |
[10] | Das SL, Singh PP, Phillips AR, et al. Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis. Gut 2014; 63: 818-31. 10.1136/gutjnl-2013-305062. |
[11] | Trounson A, McDonald C. Stem cell therapy in clinical trials: progress and challenges. A stem cell. 2015; 17: 11–22. |
[12] | Kawakubo K., Ohnishi S., Kuwatani M. et al. Mesenchymal stem cell therapy in acute and chronic pancreatitis. J Gastroenterol 53, 1–5 (2018). https://doi.org/10.1007/s00535-017-1363-9. |
[13] | Khatri, R., Mazurek, S., Petry, SF et al. Mesenchymal stem cells promote the regeneration of pancreatic β-cells by suppressing the FoxO1 pathway. Stem Cells Res Ther 11, 497 (2020). https://doi.org/10.1186/s13287-020-02007-9. |
[14] | Smukler SR, Arntfield ME, Razavi R, et al. The adult mouse and human pancreas contain rare multipotent stem cells that express insulin. Cell Stem Cell. 2011; 8: 281–93. doi: 10.1016/j.stem.2011.01.015. |
[15] | Gong J, Tian F, Ren J, Luo G. Experimental evidence supporting the lack of primary stem cells in adult pancreatic tissue. Pancreatology. 2010; 10: 620–30. doi: 10.1159/000321586. |
[16] | Wang Y, Lanzoni G, Carpino G, et al. Biliary tree stem cells, precursors to pancreatic committed progenitors: evidence for possible life-long pancreatic organogenesis. Stem Cells. 2013; 31: 1966–19. doi: 10.1002/stem.1460. |
[17] | Esrefoglu M. Stem Cell Therapies on Pancreatitis. In: Rodrigo L, editor. Acute and Chronic Pancreatitis. Rijeka: InTech; 2015. p. Ch08. |
[18] | Richardson S.M., Kalamegam G., Pushparaj P.N., Matta C., Memic A., Khademhosseini A., Mobasheri R., Poletti F.L., Hoyland J.A., Mobasheri A. Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration. Methods. 2016; 99: 69–80. doi: 10.1016/j.ymeth.2015.09.015. |
[19] | Mao F., Tu Q., Wang L., Chu F., Li X., Li H.S., Xu W. Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease. Oncotarget. 2017; 8: 38008–38021. doi: 10.18632/oncotarget.16682. |
[20] | Álvaro-Gracia J.M., Jover J.A., García-Vicuña R., Carreño L., Alonso A., Marsal S., Blanco F., Martínez-Taboada V.M., Taylor P., Martín-Martín C., et al. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Ann. Rheum. Dis. 2017; 76: 196–202. doi: 10.1136/annrheumdis-2015-208918. |
[21] | Shi Y., Su J., Roberts A.I., Shou P., Rabson A.B., Ren G. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol. 2012; 33: 136–143. doi: 10.1016/j.it.2011.11.004. |
[22] | Nitzsche F., Müller C., Lukomska B., Jolkkonen J., Deten A., Boltze J. Concise Review: MSC Adhesion Cascade-Insights into Homing and Transendothelial Migration. Stem Cells. 2017; 35: 1446–1460. doi: 10.1002/stem.2614. |
[23] | Xia X., Chiu P.W.Y., Lam P.K., Chin W.C., Ng E.K.W., Lau J.Y.W. Secretome from hypoxia-conditioned adipose-derived mesenchymal stem cells promotes the healing of gastric mucosal injury in a rodent model. Biochim. Biophys. Acta Mol. Basis Dis. 2018; 1864: 178–188. doi: 10.1016/j.bbadis.2017.10.009. |
[24] | Pouya S., Heidari M., Baghaei K., AsadzadehAghdaei H., Moradi A., Namaki S., Zali M.R., Hashemi S.M. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. Int. Immunopharmacol. 2018; 54: 86–94. doi: 10.1016/j.intimp.2017.11.001. |
[25] | Ranganath S.H., Levy O., Inamdar M.S., Karp J.M. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012; 10: 244–258. doi: 10.1016/j.stem.2012.02.005. |
[26] | Rani S., Ryan A.E., Griffin M.D., Ritter T. Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. Mol. Ther. 2015; 23:812–823. doi: 10.1038/mt.2015.44. |
[27] | Yin, G.; Hu, G.; Wan, R.; Yu, G.; Cang, X.; Ni, J.; Xiong, J.; Hu, Y.; Xing, M.; Fan, Y.; et al. Role of bone marrow mesenchymal stem cells in L-arg-induced acute pancreatitis: Effects and possible mechanisms. Int. J. Clin. Exp. Pathol. 2015, 8, 4457–4468. |
[28] | Ahmed, S.M.; Morsi, M.; Ghoneim, N.I.; Abdel-Daim, M.M.; El-Badri, N. Mesenchymal stromal cell therapy for Pancreatitis: A Systematic Review. Oxid. Med. Cell. Longev. 2018, 2018, 3250864. |
[29] | Zhao H., He Z., Huang D.et al. Infusion of Bone Marrow Mesenchymal Stem Cells Attenuates Experimental Severe Acute Pancreatitis in Rats. Stem Cells Int. 2016. |
[30] | Yin G., Hu G., Wan R.et al. Role of Microvesicles From Bone Marrow Mesenchymal Stem Cells in Acute Pancreatitis. Pancreas 2016, 45, 1282–1293. |
[31] | Hua, J.; He, Z.G.; Qian, D.H.; Lin, S.P.; Gong, J.; Meng, H.B.; Yang, T.S.; Sun, W.; Xu, B.; Zhou, B.; et al. Angiopoietin-1 gene-modified human mesenchymal stem cells promote angiogenesis and reduce acute pancreatitis in rats. Int. J. Clin. Exp. Pathol. 2014, 7, 3580–3595. |
[32] | Meng, H. B., Gong J., Zhou B., Hua J., Yao L., and Song Z. S.. 2013. Therapeutic effect of human umbilical cord-derived mesenchymal stem cells in rat severe acute pancreatitis. Int. J. Clin. Exp. Pathol. 6:2703. |
[33] | Qian, D., Gong J., He Z., Hua J., Lin S., Xu C., et al. 2015. Bone marrow-derived mesenchymal stem cells repair necrotic pancreatic tissue and promote angiogenesis by secreting cellular growth factors involved in the SDF-1α / CXCR50 axis in rats. Stem Cells Int. 2015: 1–20. |
[34] | Sala, E., Genua M., Petti L., Anselmo A., Arena V., Cibella J., et al. 2015. Mesenchymal stem cells reduce colitis in mice via release of TSG6, independently of their localization to the intestine. Gastroenterology 149: 163–176. |
[35] | Jung, K. H., Song S. U., Yi T., Jeon M. S., Hong S. W., Zheng H. M., et al. 2011. Human bone marrow–derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology 140: 998–1008. |
[36] | Yang Y, Huang Q, Luo C, Wen Y, Liu R, Sun H, Tang L. MicroRNAs in acute pancreatitis: From pathogenesis to novel diagnosis and therapy. J Cell Physiol. 2020; 235: 1948–1961. |
[37] | Zakrzewski W., Dobrzyński M., Szymonowicz M. et al. Stem cells: past, present, and future. Stem Cell Res Ther 10, 68 (2019). |
[38] | Pittenger, M.F., Discher, D.E., Péault, B.M. et al. Mesenchymal stem cell perspective: cell biology to clinical progress. npj Regen Med 4, 22 (2019). |
[39] | Bongso A, Fong CY. The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton’s jelly of the human umbilical cord. Stem Cell Rev Rep. 2013; 9(2): 226–240. |
[40] | Murray IR, West CC, Hardy WR, James AW, Park TS, Nguyen A, Tawonsawatruk T, Lazzari L, Soo C, Péault B. Natural history of mesenchymal stem cells, from vessel walls to culture vessels. Cell Mol Life Sci. 2014; 71(8): 1353–1374. |
[41] | Secco M, Zucconi E, Vieira NM, Fogaça LL, Cerqueira A, Carvalho MD, Jazedje T, Okamoto OK, Muotri AR, Zatz M. Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells. 2008; 26(1): 146–150. |
[42] | Szabó GV, Kövesd Z, Cserepes J, Daróczy J, Belkin M, Acsády G. Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease-results of the short- and long-term follow-up. Cytotherapy. 2013; 15(10): 1245–1252. |
[43] | Li, Q., Song, W. J., Ryu, M. O., Nam, A., An, J. H., Ahn, J. O., Bhang, D. H., Jung, Y. C., &Youn, H. Y. (2018). TSG-6 secreted by human adipose tissue-derived mesenchymal stem cells ameliorates severe acute pancreatitis via ER stress downregulation in mice. Stem cell research & therapy, 9(1), 255. https://doi.org/10.1186/s13287-018-1009-8. |
[44] | Huang, Q., Cheng, X., Luo, C. et al. Placental chorionic plate-derived mesenchymal stem cells ameliorate severe acute pancreatitis by regulating macrophage polarization via secreting TSG-6. Stem Cell Res Ther 12, 337 (2021). https://doi.org/10.1186/s13 Petrov M.S., Yadav D. Global epidemiology and comprehensive prevention of pancreatitis. \\ In Russian.\\ NatRevGastroenterolGepatol. 2019; 16 (3): 175–184. |
[45] | Gallyamov E.A., Agapov M.A., Lutsevich O.E., Kakotkin V.V. Modern technologies of treatment of infected pancreatic necrosis: a differentiated approach. \\ In Russian. \\ Annals of Surgical Hepatology. 2020; 25(1): 69-78. https://doi.org/10.16931/1995-5464.2020169-78. |
[46] | The use of umbilical cord blood and cord cord in the complex treatment of patients with necrotic pancreatitis / A. B. Kebkalo, G. S. Lobyntsev, V. I. Seminog, V. A. Shabli // In Russian. \\ Ukrainian Journal of Extreme Medicine named after G.A. Mozhaev. – 2012. – V. 13. – № 1. – P. 77-85. Brunschot SV, Bakker OJ, Besselink MG, et al. Treatment of necrotizing pancreatitis. Clinical Gastroenterology and Hepatology. 2012; 10(11): 1190–1201. |
[47] | Eric HJ, Daniel BC, Waddah BA, et al. Exocrine Pancreas. In: Townsend CM, et al. editors. Philadelphia; 2012. p. 1515–1531. |
[48] | Habtezion A., Gukovskaya A. S., Pandol S. J. (2019). Acute pancreatitis: a multifaceted set of organelles and cellular interactions. Gastroenterology, 156 (7), 1941-1950. https://doi.org/10.1053/j.gastro.2018.11.082. |
[49] | Forsmark CE, Vege SS, Wilcox CM. Acute pancreatitis. N Engl J Med 2016; 375: 1972–1981. |
[50] | Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis. Lancet 2020; 396: 726-34. 10.1016/S0140-6736(20)31310-6. |
[51] | Roberts S.E., Morrison-Rees S., John A., Williams J.G., Brown T.H., Samuel D.G. The incidence and aetiology of acute pancreatitis across Europe. Pancreatology. 2017; 17 (2): 155–165. |
[52] | Shah AP, Mourad MM, Bramhall SR. Acute pancreatitis: current perspectives on diagnosis and management. J Inflamm Res 2018; 11: 77-85. 10.2147/JIR.S135751. |
[53] | Machicado JD, Gougol A, Stello K, et al. Acute pancreatitis has a long-term deleterious effect on physical health related quality of life. ClinGastroenterolHepatol 2017; 15: 1435-43. e2. 10.1016/j.cgh.2017.05.037. |
[54] | Das SL, Singh PP, Phillips AR, et al. Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis. Gut 2014; 63: 818-31. 10.1136/gutjnl-2013-305062. |
[55] | Trounson A, McDonald C. Stem cell therapy in clinical trials: progress and challenges. A stem cell. 2015; 17: 11–22. |
[56] | Kawakubo K., Ohnishi S., Kuwatani M. et al. Mesenchymal stem cell therapy in acute and chronic pancreatitis. J Gastroenterol 53, 1–5 (2018). https://doi.org/10.1007/s00535-017-1363-9. |
[57] | Khatri, R., Mazurek, S., Petry, SF et al. Mesenchymal stem cells promote the regeneration of pancreatic β-cells by suppressing the FoxO1 pathway. Stem Cells Res Ther 11, 497 (2020). https://doi.org/10.1186/s13287-020-02007-9. |
[58] | Smukler SR, Arntfield ME, Razavi R, et al. The adult mouse and human pancreas contain rare multipotent stem cells that express insulin. Cell Stem Cell. 2011; 8: 281–93. doi: 10.1016/j.stem.2011.01.015. |
[59] | Gong J, Tian F, Ren J, Luo G. Experimental evidence supporting the lack of primary stem cells in adult pancreatic tissue. Pancreatology. 2010; 10: 620–30. doi: 10.1159/000321586. |
[60] | Wang Y, Lanzoni G, Carpino G, et al. Biliary tree stem cells, precursors to pancreatic committed progenitors: evidence for possible life-long pancreatic organogenesis. Stem Cells. 2013; 31: 1966–19. doi: 10.1002/stem.1460. |
[61] | Esrefoglu M. Stem Cell Therapies on Pancreatitis. In: Rodrigo L, editor. Acute and Chronic Pancreatitis. Rijeka: InTech; 2015. p. Ch08. |
[62] | Richardson S.M., Kalamegam G., Pushparaj P.N., Matta C., Memic A., Khademhosseini A., Mobasheri R., Poletti F.L., Hoyland J.A., Mobasheri A. Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration. Methods. 2016; 99: 69–80. doi: 10.1016/j.ymeth.2015.09.015. |
[63] | Mao F., Tu Q., Wang L., Chu F., Li X., Li H.S., Xu W. Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease. Oncotarget. 2017; 8: 38008–38021. doi: 10.18632/oncotarget.16682. |
[64] | Álvaro-Gracia J.M., Jover J.A., García-Vicuña R., Carreño L., Alonso A., Marsal S., Blanco F., Martínez-Taboada V.M., Taylor P., Martín-Martín C., et al. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Ann. Rheum. Dis. 2017; 76: 196–202. doi: 10.1136/annrheumdis-2015-208918. |
[65] | Shi Y., Su J., Roberts A.I., Shou P., Rabson A.B., Ren G. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol. 2012; 33: 136–143. doi: 10.1016/j.it.2011.11.004. |
[66] | Nitzsche F., Müller C., Lukomska B., Jolkkonen J., Deten A., Boltze J. Concise Review: MSC Adhesion Cascade-Insights into Homing and Transendothelial Migration. Stem Cells. 2017; 35: 1446–1460. doi: 10.1002/stem.2614. |
[67] | Xia X., Chiu P.W.Y., Lam P.K., Chin W.C., Ng E.K.W., Lau J.Y.W. Secretome from hypoxia-conditioned adipose-derived mesenchymal stem cells promotes the healing of gastric mucosal injury in a rodent model. Biochim. Biophys. Acta Mol. Basis Dis. 2018; 1864: 178–188. doi: 10.1016/j.bbadis.2017.10.009. |
[68] | Pouya S., Heidari M., Baghaei K., Asadzadeh Aghdaei H., Moradi A., Namaki S., Zali M.R., Hashemi S.M. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. Int. Immunopharmacol. 2018; 54: 86–94. doi: 10.1016/j.intimp.2017.11.001. |
[69] | Ranganath S.H., Levy O., Inamdar M.S., Karp J.M. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012; 10: 244–258. doi: 10.1016/j.stem.2012.02.005. |
[70] | Rani S., Ryan A.E., Griffin M.D., Ritter T. Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. Mol. Ther. 2015; 23:812–823. doi: 10.1038/mt.2015.44. |
[71] | Prockop D.J., Oh J.Y. Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Mol. Ther. 2012; 20: 14–20. doi: 10.1038/mt.2011.211. |
[72] | Jiang W., Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020; 53: e12712. doi: 10.1111/cpr.12712. |
[73] | Melief S.M., Schrama E., Brugman M.H., Tiemessen M.M., Hoogduijn M.J., Fibbe W.E., Roelofs H. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells. 2013; 31: 1980–1991. doi: 10.1002/stem.1432. |
[74] | Wang Y., Chen X., Cao W., Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: Pathological and therapeutic implications. Nat. Immunol. 2014; 15: 1009–1016. doi: 10.1038/ni.3002. |
[75] | Liu J., Liu Q., Chen X. The Immunomodulatory Effects of Mesenchymal Stem Cells on Regulatory B Cells. Front. Immunol. 2020; 11: 1843. doi: 10.3389/fimmu.2020.01843. |
[76] | Chen X., Cai C., Xu D., Liu Q., Zheng S., Liu L., Li G., Zhang X., Li X., Ma Y., et al. Human Mesenchymal Stem Cell-Treated Regulatory CD23+CD43+ B Cells Alleviate Intestinal Inflammation. Theranostics. 2019; 9: 4633–4647. doi: 10.7150/thno.32260. |
[77] | Pérez-Merino, E. M., Usón-Casaús J. M., Duque-Carrasco J., Zaragoza-Bayle C., Mariñas-Pardo L., Hermida-Prieto M., et al. 2015. Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: endoscopic and histological outcomes. Vet. J. 206: 391–397. |
[78] | Volarevic, V., Nurkovic J., Arsenijevic N., and Stojkovic M.. 2014. Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells 32:2818–2823. |
[79] | Wise, A. F. , Williams T. M., Kiewiet M. B., Payne N. L., Siatskas C., Samuel C. S., et al. 2014. Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury. Am. J. Physiol. Renal. Physiol. 306: F1222–F1235. |
[80] | Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease / R. Ciccocioppo, M. E. Bernardo, M. L. Russo, et al. // J. Pediatr. Gastroenterol. Nutr. – 2013. – Vol. 56, № 4. – P. 422-427. |
[81] | Effect of the IkBα mutant gene delivery to mesenchymal stem cells on rat chronic pancreatitis / T. Qin, C. J. Liu, H. W. Zhang, et al. // Genet Mol Res. – 2014. – Vol. 13, № 1. – P. 371-385. |
[82] | Therapeutic effect of human umbilical cord-derived mesenchymal stem cells in rat severe acute pancreatitis / Hong-Bo Meng, Jian Gong, Bo Zhou, et al. // Int. J. Clin. Exp. Pathol. – 2013. – Vol. 6, № 12. – P. 2703-2712. |
[83] | Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors / S. Watanabe, Y. Arimura, K. Nagaishi, et al. // J. Gastroenterol. – 2014. – Vol. 49, № 2. – P. 270-282. |
[84] | Immunosuppressive properties of mesenchymal stem cells: advances and applications / M. P. De Miguel, S. Fuentes-Julián, A. Blázquez-Martínez, et al. // Curr. Mol. Med. – 2012. – Vol. 12, № 5. – P. 574-591. |
[85] | Lanthier N. Liver progenitor cells and therapeutic potential of stem cells in human chronic liver diseases / N. Lanthier, L Rubbia-Brandt, L. Spahr // ActaGastroenterol Belg. – 2013. – Vol. 76, № 1. – P. 3-9. |
[86] | Jung, K. H., Song S. U., Yi T., Jeon M. S., Hong S. W., Zheng H. M., et al. 2011. Human bone marrow–derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology 140: 998–1008. |
[87] | Tu, X. H. , Song J. X., Xue X. J., Guo X. W., Ma Y. X., Chen Z. Y., et al. 2012. Role of bone marrow-derived mesenchymal stem cells in a rat model of severe acute pancreatitis. World J. Gastroenterol. 18: 2270. |
[88] | Yin G., Hu G., Wan R., Yu G., Cang X., Xiong J., et al. 2016. Role of microvesicles from bone marrow mesenchymal stem cells in acute pancreatitis. Pancreas 45: 1282–1293. |
[89] | Yin, G.; Hu, G.; Wan, R.; Yu, G.; Cang, X.; Ni, J.; Xiong, J.; Hu, Y.; Xing, M.; Fan, Y.; et al. Role of bone marrow mesenchymal stem cells in L-arg-induced acute pancreatitis: Effects and possible mechanisms. Int. J. Clin. Exp. Pathol. 2015, 8, 4457–4468. |
[90] | Ahmed, S.M.; Morsi, M.; Ghoneim, N.I.; Abdel-Daim, M.M.; El-Badri, N. Mesenchymal stromal cell therapy for Pancreatitis: A Systematic Review. Oxid. Med. Cell. Longev. 2018, 2018, 3250864. |
[91] | Zhao H., He Z., Huang D. et al. Infusion of Bone Marrow Mesenchymal Stem Cells Attenuates Experimental Severe Acute Pancreatitis in Rats. Stem Cells Int. 2016. |
[92] | Yin G., Hu G., Wan R. et al. Role of Microvesicles From Bone Marrow Mesenchymal Stem Cells in Acute Pancreatitis. Pancreas 2016, 45, 1282–1293. |
[93] | Hua, J.; He, Z.G.; Qian, D.H.; Lin, S.P.; Gong, J.; Meng, H.B.; Yang, T.S.; Sun, W.; Xu, B.; Zhou, B.; et al. Angiopoietin-1 gene-modified human mesenchymal stem cells promote angiogenesis and reduce acute pancreatitis in rats. Int. J. Clin. Exp. Pathol. 2014, 7, 3580–3595. |
[94] | Meng, H. B., Gong J., Zhou B., Hua J., Yao L., and Song Z. S.. 2013. Therapeutic effect of human umbilical cord-derived mesenchymal stem cells in rat severe acute pancreatitis. Int. J. Clin. Exp. Pathol. 6: 2703. |
[95] | Qian, D., Gong J., He Z., Hua J., Lin S., Xu C., et al. 2015. Bone marrow-derived mesenchymal stem cells repair necrotic pancreatic tissue and promote angiogenesis by secreting cellular growth factors involved in the SDF-1α / CXCR50 axis in rats. Stem Cells Int. 2015: 1–20. |
[96] | Sala, E., Genua M., Petti L., Anselmo A., Arena V., Cibella J., et al. 2015. Mesenchymal stem cells reduce colitis in mice via release of TSG6, independently of their localization to the intestine. Gastroenterology 149: 163–176. |
[97] | Yang Y, Huang Q, Luo C, Wen Y, Liu R, Sun H, Tang L. MicroRNAs in acute pancreatitis: From pathogenesis to novel diagnosis and therapy. J Cell Physiol. 2020; 235: 1948–1961. |
[98] | Zakrzewski W., Dobrzyński M., Szymonowicz M. et al. Stem cells: past, present, and future. Stem Cell Res Ther 10, 68 (2019). |
[99] | Pittenger, M.F., Discher, D.E., Péault, B.M. et al. Mesenchymal stem cell perspective: cell biology to clinical progress. npj Regen Med 4, 22 (2019). |
[100] | Bongso A, Fong CY. The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton’s jelly of the human umbilical cord. Stem Cell Rev Rep. 2013; 9(2): 226–240. |
[101] | Murray IR, West CC, Hardy WR, James AW, Park TS, Nguyen A, Tawonsawatruk T, Lazzari L, Soo C, Péault B. Natural history of mesenchymal stem cells, from vessel walls to culture vessels. Cell Mol Life Sci. 2014; 71(8): 1353–1374. |
[102] | Secco M, Zucconi E, Vieira NM, Fogaça LL, Cerqueira A, Carvalho MD, Jazedje T, Okamoto OK, Muotri AR, Zatz M. Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells. 2008; 26(1): 146–150. |
[103] | Szabó GV, Kövesd Z, Cserepes J, Daróczy J, Belkin M, Acsády G. Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease-results of the short- and long-term follow-up. Cytotherapy. 2013; 15(10): 1245–1252. |
[104] | Li, Q., Song, W. J., Ryu, M. O., Nam, A., An, J. H., Ahn, J. O., Bhang, D. H., Jung, Y. C., & Youn, H. Y. (2018). TSG-6 secreted by human adipose tissue-derived mesenchymal stem cells ameliorates severe acute pancreatitis via ER stress downregulation in mice. Stem cell research & therapy, 9(1), 255. https://doi.org/10.1186/s13287-018-1009-8. |
[105] | Huang, Q., Cheng, X., Luo, C. et al. Placental chorionic plate-derived mesenchymal stem cells ameliorate severe acute pancreatitis by regulating macrophage polarization via secreting TSG-6. Stem Cell Res Ther 12, 337 (2021). https://doi.org/10.1186/s13287-021-02411-9. |